Insider · CIK 0001235946

JEW JEANNE Y

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001235946

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-09-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2003-12-02	ONYX PHARMACEUTICALS INCM Exercise/Conversion	VP, Corporate & Commercial Dev	MExercise/Conversion	+15K sh	$6.46	+$96.9K	15,000
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−400 sh	$29.80	−$11.9K	14,600
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−1,500 sh	$29.79	−$44.7K	13,100
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−300 sh	$29.78	−$8,934	12,800
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−300 sh	$29.77	−$8,931	12,500
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.76	−$2,976	12,400
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−700 sh	$29.74	−$20.8K	11,700
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.73	−$2,973	11,600
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−500 sh	$29.72	−$14.9K	11,100
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−1,400 sh	$29.70	−$41.6K	9,700
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.64	−$2,964	9,600
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.60	−$2,960	9,500
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.58	−$2,958	9,400
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−600 sh	$29.55	−$17.7K	8,800
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−200 sh	$29.50	−$5,901	8,600
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−700 sh	$29.51	−$20.7K	7,900
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−500 sh	$29.52	−$14.8K	7,400
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−675 sh	$29.50	−$19.9K	6,725
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−400 sh	$29.46	−$11.8K	6,325
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.43	−$2,943	6,225
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−5,825 sh	$29.42	−$171K	400
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.41	−$2,941	300
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−200 sh	$29.40	−$5,880	100
2003-12-02	ONYX PHARMACEUTICALS INCS Sale	VP, Corporate & Commercial Dev	SSale	−100 sh	$29.32	−$2,932	0
2003-12-02	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	VP, Corporate & Commercial Dev	MExercise/Conversion	−15K sh	—	—	85,000

Recent filings

Accepted (ET)
Sep 134
JEW JEANNE Y0001209191-21-055780
SEC(opens sec.gov)
Dec 34
JEW JEANNE Y0001209191-03-033346
SEC(opens sec.gov)

Companies

Address

C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710

SOUTH SAN FRANCISCO, CA, 94080